HSBC Holdings
ASMB icon

HSBC Holdings’s Assembly Biosciences ASMB Stock Holding History

HSBC Holdings’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
+16,935
New +$461K ﹤0.01% 2899
2024
Q1 		– Sell
-951
Closed -$9.42K – 3046
2023
Q4 		$9.42K Hold
951
– – ﹤0.01% 2692
2023
Q3 		$10.2K Hold
951
– – ﹤0.01% 2682
2023
Q2 		$12.8K Hold
951
– – ﹤0.01% 2531
2023
Q1 		$9.53K Hold
951
– – ﹤0.01% 2623
2022
Q4 		$14.3K Sell
951
-56
-6% -$957 ﹤0.01% 3025
2022
Q3 		$20K Sell
1,007
-200
-17% -$4.84K ﹤0.01% 2872
2022
Q2 		$31K Sell
1,207
-347
-22% -$7.99K ﹤0.01% 3172
2022
Q1 		$38K Hold
1,554
– – ﹤0.01% 3213
2021
Q4 		$44K Buy
+1,554
New +$51K ﹤0.01% 3208
2019
Q4 		– Sell
-2,347
Closed -$277K – 3026
2019
Q3 		$277K Buy
+2,347
New +$355K ﹤0.01% 2673
2018
Q3 		– Sell
-871
Closed -$410K – 2532
2018
Q2 		$410K Sell
871
-788
-47% -$417K ﹤0.01% 2149
2018
Q1 		$978K Sell
1,659
-1,707
-51% -$1.06M ﹤0.01% 1646
2017
Q4 		$1.83M Buy
+3,366
New +$1.52M ﹤0.01% 1140
2017
Q2 		– Sell
-674
Closed -$206K – 2183
2017
Q1 		$206K Buy
+674
New +$165K ﹤0.01% 1987

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HSBC Holdings's ASMB Position: Q2 2026 in Review

HSBC Holdings opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 16,935 shares worth $17.1K. The stake represents ﹤0.01% of the portfolio and ranks #2899 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in ASMB as recently as Q4 2023.

HSBC Holdings first reported a position in ASMB in Q1 2017 and has held it in 15 quarters since. The position peaked at $1.83M in Q4 2017. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • HSBC Holdings held 16,935 shares of Assembly Biosciences worth $17.1K as of Q2 2026.
  • Assembly Biosciences was a new HSBC Holdings position in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2899 holding.
  • HSBC Holdings first reported a position in Assembly Biosciences in Q1 2017 and has held it in 15 quarters since.
  • HSBC Holdings's Assembly Biosciences position peaked at $1.83M in Q4 2017.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.